Cracking the Toll-like receptor code in fungal infections

References

• Romani L. Overview of the fungal pathogens. In: Immunology of Infectious Diseases. Kaufman SHE, Sher A, Ahmed R (Eds). ASM Press, Washington DC, USA, 25–37 (2001).
   Google Scholar
• Cooney NM, Klein BS. Fungal adaptation to the mammalian host: it is a new world, after all. Curr. Opin. Microbiol.11(6), 511–516 (2008).
   PubMedGoogle Scholar
• Hube B. Fungal adaptation to the host environment. Curr. Opin. Microbiol.12(4), 347–349 (2009).
   PubMed Web of Science ®Google Scholar
• Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. Eur. J. Pediatr.166(11), 1099–1117 (2007).
   PubMed Web of Science ®Google Scholar
• Carneiro-Sampaio M, Coutinho A. Immunity to microbes: lessons from primary immunodeficiencies. Infect. Immun.75(4), 1545–1555 (2007).
   PubMed Web of Science ®Google Scholar
• Pappas PG, Alexander BD, Andes DR et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin. Infect. Dis.50(8), 1101–1111 (2010).
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Marr KA, Park BJ et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin. Infect. Dis.50(8), 1091–1100 (2010).
   PubMed Web of Science ®Google Scholar
• Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect. Dis.7(6), 395–401 (2007).
   PubMed Web of Science ®Google Scholar
• Simon-Nobbe B, Denk U, Poll V, Rid R, Breitenbach M. The spectrum of fungal allergy. Int. Arch. Allergy Immunol.145(1), 58–86 (2008).
   PubMed Web of Science ®Google Scholar
• Denning DW, O’Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur. Respir. J.27(3), 615–626 (2006).
   PubMed Web of Science ®Google Scholar
• Romani L, Puccetti P. Immune regulation and tolerance to fungi in the lungs and skin. Chem. Immunol. Allergy94, 124–137 (2008).
   PubMedGoogle Scholar
• Odds FC, Jacobsen MD. Multilocus sequence typing of pathogenic Candida species. Eukaryot. Cell7(7), 1075–1084 (2008).
   PubMedGoogle Scholar
• Romani L. Immunity to fungal infections. Nat. Rev. Immunol.4(1), 1–23 (2004).
   PubMed Web of Science ®Google Scholar
• Shoham S, Levitz SM. The immune response to fungal infections. Br. J. Haematol.129(5), 569–582 (2005).
   PubMedGoogle Scholar
• Romani L, Fallarino F, De Luca A et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature451(7175), 211–215 (2008).
   PubMed Web of Science ®Google Scholar
• Romani L, Puccetti P. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol.14(4), 183–189 (2006).
   PubMed Web of Science ®Google Scholar
• Filipe-Santos O, Bustamante J, Chapgier A et al. Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features. Semin. Immunol.18(6), 347–361 (2006).
   PubMed Web of Science ®Google Scholar
• Lilic D. New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr. Opin. Infect. Dis.15(2), 143–147 (2002).
   PubMed Web of Science ®Google Scholar
• Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity30(5), 646–655 (2009).
   PubMed Web of Science ®Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu. Rev. Immunol.27, 485–517 (2009).
   PubMed Web of Science ®Google Scholar
• Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol.6(4), 329–333 (2006).
   PubMed Web of Science ®Google Scholar
• Romani L, Puccetti P. Controlling pathogenic inflammation to fungi. Expert Rev. Anti Infect. Ther.5(6), 1007–1017 (2007).
   PubMed Web of Science ®Google Scholar
• Carvalho A, Cunha C, Di Ianni M et al. Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. Bone Marrow Transplant. DOI: 10.1038/bmt.2010.28 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Happel KI, Dubin PJ, Zheng M et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med.202(6), 761–769 (2005).
   PubMed Web of Science ®Google Scholar
• Zelante T, De Luca A, Bonifazi P et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol.37(10), 2695–2706 (2007).
   PubMed Web of Science ®Google Scholar
• De Luca A, Montagnoli C, Zelante T et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J. Immunol.179(9), 5999–6008 (2007).
   PubMed Web of Science ®Google Scholar
• Heninger E, Hogan LH, Karman J et al. Characterization of the Histoplasma capsulatum-induced granuloma. J. Immunol.177(5), 3303–3313 (2006).
   PubMed Web of Science ®Google Scholar
• Leibundgut-Landmann S, Gross O, Robinson MJ et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol.8(6), 630–638 (2007).
   PubMed Web of Science ®Google Scholar
• van de Veerdonk FL, Marijnissen RJ, Kullberg BJ et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe5(4), 329–340 (2009).
   PubMed Web of Science ®Google Scholar
• Kleinschek MA, Muller U, Brodie SJ et al. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J. Immunol.176(2), 1098–1106 (2006).
   PubMed Web of Science ®Google Scholar
• Rizzetto L, Kuka M, De Filippo C et al. Differential IL-17 production and mannan recognition contribute to fungal pathogenicity and commensalism. J. Immunol.184(8), 4258–4268 (2010).
   PubMedGoogle Scholar
• Armstrong-James DP, Turnbull SA, Teo I et al. Impaired interferon-γ responses, increased interleukin-17 expression, and a tumor necrosis factor-α transcriptional program in invasive aspergillosis. J. Infect. Dis.200(8), 1341–1351 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang F, Tompkins KC et al. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am. J. Pathol.175(6), 2489–2500 (2009).
   PubMed Web of Science ®Google Scholar
• Fenoglio D, Poggi A, Catellani S et al. Vdelta1 T lymphocytes producing IFN-γ and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood113(26), 6611–6618 (2009).
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol.8(9), 942–949 (2007).
   PubMed Web of Science ®Google Scholar
• Bozza S, Clavaud C, Giovannini G et al. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J. Immunol.183, 2407–2414 (2009).
   PubMed Web of Science ®Google Scholar
• Chai LY, van de Veerdonk F, Marijnissen RJ et al. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology130(1), 46–54 (2009).
   PubMedGoogle Scholar
• Milner JD, Brenchley JM, Laurence A et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature452(7188), 773–776 (2008).
   PubMed Web of Science ®Google Scholar
• Ferwerda B, Ferwerda G, Plantinga TS et al. Human Dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med.361(18), 1760–1767 (2009).
   PubMed Web of Science ®Google Scholar
• Conti HR, Shen F, Nayyar N et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med.206(2), 299–311 (2009).
   PubMed Web of Science ®Google Scholar
• Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis.190(3), 624–631 (2004).
   PubMed Web of Science ®Google Scholar
• Zelante T, De Luca A, D’Angelo C, Moretti S, Romani L. IL-17/Th17 in anti-fungal immunity: what’s new? Eur. J. Immunol.39(3), 645–648 (2009).
   PubMed Web of Science ®Google Scholar
• De Luca A, Zelante T, D’Angelo C et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol.3(4), 361–373 (2010).
   PubMed Web of Science ®Google Scholar
• Romani L, Zelante T, De Luca A, Fallarino F, Puccetti P. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J. Immunol.180(8), 5157–5162 (2008).
   PubMed Web of Science ®Google Scholar
• Zenewicz LA, Flavell RA. IL-22 and inflammation: leukin’ through a glass onion. Eur. J. Immunol.38(12), 3265–3268 (2008).
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell124(4), 783–801 (2006).
   PubMed Web of Science ®Google Scholar
• Gribar SC, Richardson WM, Sodhi CP, Hackam DJ. No longer an innocent bystander: epithelial Toll-like receptor signaling in the development of mucosal inflammation. Mol. Med.14(9–10), 645–659 (2008).
   PubMed Web of Science ®Google Scholar
• Weindl G, Naglik JR, Kaesler S et al. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J. Clin. Invest.117(12), 3664–3672 (2007).
   PubMed Web of Science ®Google Scholar
• De Luca A, Bozza S, Zelante T et al. Nonhematopoietic cells contribute to protective tolerance to Aspergillus fumigatus via a TRIF pathway converging on IDO. Cell. Mol. Immunol. DOI:10.1038/cmi.2010.43 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• Mayer AK, Bartz H, Fey F, Schmidt LM, Dalpke AH. Airway epithelial cells modify immune responses by inducing an anti-inflammatory microenvironment. Eur. J. Immunol.38(6), 1689–1699 (2008).
   PubMed Web of Science ®Google Scholar
• Balloy V, Sallenave JM, Wu Y et al.Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the Toll-like receptor-MyD88 pathway. J. Biol. Chem.283(45), 30513–30521 (2008).
   PubMed Web of Science ®Google Scholar
• Reaves TA, Chin AC, Parkos CA. Neutrophil transepithelial migration: role of Toll-like receptors in mucosal inflammation. Mem. Inst. Oswaldo Cruz100(Suppl. 1), 191–198 (2005).
   PubMedGoogle Scholar
• Chignard M, Balloy V, Sallenave JM, Si-Tahar M. Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts. Clin. Immunol.124(3), 238–243 (2007).
   PubMed Web of Science ®Google Scholar
• Netea MG, Brown GD, Kullberg BJ, Gow NA. An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol.6(1), 67–78 (2008).
   PubMed Web of Science ®Google Scholar
• Romani L. Cell mediated immunity to fungi: a reassessment. Med. Mycol.46(6), 515–529 (2008).
   PubMed Web of Science ®Google Scholar
• Bellocchio S, Montagnoli C, Bozza S et al. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol.172(5), 3059–3069 (2004).
   PubMed Web of Science ®Google Scholar
• Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol.6(1), 33–43 (2006).
   PubMed Web of Science ®Google Scholar
• Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J.24(6), 1277–1286 (2005).
   PubMed Web of Science ®Google Scholar
• Saijo S, Fujikado N, Furuta T et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat. Immunol.8(1), 39–46 (2007).
   PubMed Web of Science ®Google Scholar
• Werner JL, Metz AE, Horn D et al. Requisite role for the Dectin-1 β-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol.182(8), 4938–4946 (2009).
   PubMed Web of Science ®Google Scholar
• Gross O, Gewies A, Finger K et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature442(7103), 651–656 (2006).
   PubMed Web of Science ®Google Scholar
• Gringhuis SI, den Dunnen J, Litjens M et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk. Nat. Immunol.10(2), 203–213 (2009).
   PubMed Web of Science ®Google Scholar
• Heinsbroek SE, Brown GD, Gordon S. Dectin-1 escape by fungal dimorphism. Trends Immunol.26(7), 352–354 (2005).
   PubMed Web of Science ®Google Scholar
• Rappleye CA, Eissenberg LG, Goldman WE. Histoplasma capsulatum α-(1,3)-glucan blocks innate immune recognition by the β-glucan receptor. Proc. Natl Acad. Sci. USA104(4), 1366–1370 (2007).
   PubMed Web of Science ®Google Scholar
• Plantinga TS, van der Velden WJ, Ferwerda B et al. Early stop polymorphism in human DECTIN-1 is associated with increased Candida colonization in hematopoietic stem cell transplant recipients. Clin. Infect. Dis.49(5), 724–732 (2009).
   PubMed Web of Science ®Google Scholar
• Lee HM, Yuk JM, Shin DM, Jo EK. Dectin-1 is inducible and plays an essential role for mycobacteria-induced innate immune responses in airway epithelial cells. J. Clin. Immunol.29(6), 795–805 (2009).
   PubMedGoogle Scholar
• Bonifazi P, D’Angelo C, Zagarella S et al. Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol.3(2), 193–205 (2010).
   PubMed Web of Science ®Google Scholar
• Bonifazi P, Zelante T, D’Angelo C et al. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol.2(4), 362–374 (2009).
   PubMed Web of Science ®Google Scholar
• Puccetti P, Grohmann U. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation. Nat. Rev. Immunol.7(10), 817–823 (2007).
   PubMed Web of Science ®Google Scholar
• Bellocchio S, Moretti S, Perruccio K et al. TLRs govern neutrophil activity in aspergillosis. J. Immunol.173(12), 7406–7415 (2004).
   PubMed Web of Science ®Google Scholar
• van de Veerdonk FL, Kullberg BJ, van der Meer JW, Gow NA, Netea MG. Host–microbe interactions: innate pattern recognition of fungal pathogens. Curr. Opin. Microbiol.11(4), 305–312 (2008).
   PubMed Web of Science ®Google Scholar
• Behnsen J, Narang P, Hasenberg M et al. Environmental dimensionality controls the interaction of phagocytes with the pathogenic fungi Aspergillus fumigatus and Candida albicans. PLoS Pathog.3(2), e13 (2007).
   Web of Science ®Google Scholar
• Said-Sadier N, Padilla E, Langsley G, Ojcius DM. Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase. PLoS One5(4), e10008 (2010).
   PubMed Web of Science ®Google Scholar
• Kumar H, Kumagai Y, Tsuchida T et al. Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal β-glucan. J. Immunol.183(12), 8061–8067 (2009).
   PubMed Web of Science ®Google Scholar
• Gross O, Poeck H, Bscheider M et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature459(7245), 433–436 (2009).
   PubMed Web of Science ®Google Scholar
• Hise AG, Tomalka J, Ganesan S et al. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe5(5), 487–497 (2009).
   PubMed Web of Science ®Google Scholar
• Joly S, Ma N, Sadler JJ et al. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J. Immunol.183(6), 3578–3581 (2009).
   PubMed Web of Science ®Google Scholar
• Lev-Sagie A, Prus D, Linhares IM et al. Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome. Am. J. Obstet. Gynecol.200(3), 303 e301–e306 (2009).
   PubMedGoogle Scholar
• Bauernfeind FG, Horvath G, Stutz A et al. Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol.183(2), 787–791 (2009).
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol.7(3), 179–190 (2007).
   PubMed Web of Science ®Google Scholar
• Chai LY, Kullberg BJ, Vonk AG et al. Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect. Immun.77(5), 2184–2192 (2009).
   PubMed Web of Science ®Google Scholar
• Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell86(6), 973–983 (1996).
   PubMed Web of Science ®Google Scholar
• Carvalho A, Cunha C, Pasqualotto AC et al. Genetic variability of innate immunity impacts human susceptibility to fungal diseases. Int. J. Infect. Dis.14(6), e460–e468 (2009).
   Google Scholar
• Jouault T, Ibata-Ombetta S, Takeuchi O et al.Candida albicans phospholipomannan is sensed through Toll-like receptors. J. Infect. Dis.188(1), 165–172 (2003).
   PubMed Web of Science ®Google Scholar
• Netea MG, Van Der Graaf CA, Vonk AG et al. The role of to–ll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis.185(10), 1483–1489 (2002).
   PubMed Web of Science ®Google Scholar
• Villamon E, Gozalbo D, Roig P et al. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect.6(1), 1–7 (2004).
   PubMed Web of Science ®Google Scholar
• Blasi E, Mucci A, Neglia R et al. Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans. FEMS Immunol. Med. Microbiol.44(1), 69–79 (2005).
   PubMedGoogle Scholar
• Yanez A, Flores A, Murciano C et al. Signalling through TLR2/MyD88 induces differentiation of murine bone marrow stem and progenitor cells to functional phagocytes in response to Candida albicans. Cell. Microbiol.12(1), 114–128 (2010).
   PubMedGoogle Scholar
• Netea MG, van de Veerdonk F, Verschueren I, van der Meer JW, Kullberg BJ. Role of TLR1 and TLR6 in the host defense against disseminated candidiasis. FEMS Immunol. Med. Microbiol.52(1), 118–123 (2008).
   PubMed Web of Science ®Google Scholar
• Wang JE, Warris A, Ellingsen EA et al. Involvement of CD14 and Toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect. Immun.69(4), 2402–2406 (2001).
   PubMed Web of Science ®Google Scholar
• Balloy V, Si-Tahar M, Takeuchi O et al. Involvement of Toll-like receptor 2 in experimental invasive pulmonary aspergillosis. Infect. Immun.73(9), 5420–5425 (2005).
   PubMed Web of Science ®Google Scholar
• Shoham S, Huang C, Chen JM, Golenbock DT, Levitz SM. Toll-like receptor 4 mediates intracellular signaling without TNF-α release in response to Cryptococcus neoformans polysaccharide capsule. J. Immunol.166(7), 4620–4626 (2001).
   PubMed Web of Science ®Google Scholar
• Biondo C, Midiri A, Messina L et al. MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans. Eur. J. Immunol.35(3), 870–878 (2005).
   PubMed Web of Science ®Google Scholar
• Yauch LE, Mansour MK, Shoham S, Rottman JB, Levitz SM. Involvement of CD14, Toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformansin vivo. Infect. Immun.72(9), 5373–5382 (2004).
   PubMed Web of Science ®Google Scholar
• Loures FV, Pina A, Felonato M, Calich VL. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J. Immunol.183(2), 1279–1290 (2009).
   PubMed Web of Science ®Google Scholar
• Tada H, Nemoto E, Shimauchi H et al.Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor a by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol. Immunol.46(7), 503–512 (2002).
   PubMed Web of Science ®Google Scholar
• Netea MG, Gow NA, Munro CA et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest.116(6), 1642–1650 (2006).
   PubMed Web of Science ®Google Scholar
• Gasparoto TH, Tessarolli V, Garlet TP et al. Absence of functional TLR4 impairs response of macrophages after Candida albicans infection. Med. Mycol. DOI: 10.3109/13693786.2010.481292 (2010) (Epub ahead of print).
   Google Scholar
• d’Ostiani CF, Del Sero G, Bacci A et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med.191(10), 1661–1674 (2000).
   PubMed Web of Science ®Google Scholar
• Villamon E, Gozalbo D, Roig P et al. Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida-induced production of cytokines. Eur. Cytokine Netw.15(3), 263–271 (2004).
   PubMed Web of Science ®Google Scholar
• Marr KA, Balajee SA, Hawn TR et al. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Infect. Immun.71(9), 5280–5286 (2003).
   PubMed Web of Science ®Google Scholar
• Romani L, Bistoni F, Perruccio K et al. Thymosin α1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood108(7), 2265–2274 (2006).
   PubMed Web of Science ®Google Scholar
• Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J. Biol. Chem.277(42), 39320–39326 (2002).
   PubMed Web of Science ®Google Scholar
• Bozza S, Zelante T, Moretti S et al. Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J. Immunol.180(6), 4022–4031 (2008).
   PubMed Web of Science ®Google Scholar
• Dubourdeau M, Athman R, Balloy V et al.Aspergillus fumigatus induces innate immune responses in alveolar macrophages through the MAPK pathway independently of TLR2 and TLR4. J. Immunol.177(6), 3994–4001 (2006).
   PubMed Web of Science ®Google Scholar
• Bretz C, Gersuk G, Knoblaugh S et al. MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus. Infect. Immun.76(3), 952–958 (2008).
   PubMed Web of Science ®Google Scholar
• Rivera A, Ro G, Van Epps HL et al. Innate immune activation and CD4+ T cell priming during respiratory fungal infection. Immunity25(4), 665–675 (2006).
   PubMed Web of Science ®Google Scholar
• Ding K, Shibui A, Wang Y et al. Impaired recognition by Toll-like receptor 4 is responsible for exacerbated murine Pneumocystis pneumonia. Microbes Infect.7(2), 195–203 (2005).
   PubMedGoogle Scholar
• Nakamura K, Miyagi K, Koguchi Y et al. Limited contribution of Toll-like receptor 2 and 4 to the host response to a fungal infectious pathogen, Cryptococcus neoformans. FEMS Immunol. Med. Microbiol.47(1), 148–154 (2006).
   PubMedGoogle Scholar
• Loures FV, Pina A, Felonato M et al. Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells. Infect. Immun.78(3), 1078–1088 (2010).
   PubMed Web of Science ®Google Scholar
• Miyazato A, Nakamura K, Yamamoto N et al. Toll-like receptor 9-dependent activation of myeloid dendritic cells by deoxynucleic acids from Candida albicans. Infect. Immun.77(7), 3056–3064 (2009).
   PubMed Web of Science ®Google Scholar
• Nakamura K, Miyazato A, Xiao G et al. Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway. J. Immunol.180(6), 4067–4074 (2008).
   PubMed Web of Science ®Google Scholar
• Ramirez-Ortiz ZG, Specht CA, Wang JP et al. Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect. Immun.76(5), 2123–2129 (2008).
   PubMed Web of Science ®Google Scholar
• Bozza S, Gaziano R, Lipford GB et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect.4(13), 1281–1290 (2002).
   PubMed Web of Science ®Google Scholar
• Ramaprakash H, Ito T, Standiford TJ, Kunkel SL, Hogaboam CM. Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice. Infect. Immun.77(1), 108–119 (2009).
   PubMedGoogle Scholar
• Park SJ, Hughes MA, Burdick M, Strieter RM, Mehrad B. Early NK cell-derived IFN-γ is essential to host defense in neutropenic invasive aspergillosis. J. Immunol.182(7), 4306–4312 (2009).
   PubMed Web of Science ®Google Scholar
• Steele C, Rapaka RR, Metz A et al. The β-glucan receptor Dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog.1(4), e42 (2005).
   PubMed Web of Science ®Google Scholar
• Taylor PR, Tsoni SV, Willment JA et al. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nat. Immunol.8(1), 31–38 (2007).
   PubMed Web of Science ®Google Scholar
• Nakamura K, Kinjo T, Saijo S et al. Dectin-1 is not required for the host defense to Cryptococcus neoformans. Microbiol. Immunol.51(11), 1115–1119 (2007).
   PubMed Web of Science ®Google Scholar
• Giles SS, Dagenais TR, Botts MR, Keller NP, Hull CM. Elucidating the pathogenesis of spores from the human fungal pathogen Cryptococcus neoformans. Infect. Immun.77(8), 3491–3500 (2009).
   PubMed Web of Science ®Google Scholar
• Bonfim CV, Mamoni RL, Blotta MH. TLR-2, TLR-4 and Dectin-1 expression in human monocytes and neutrophils stimulated by Paracoccidioides brasiliensis. Med. Mycol.47(7), 722–733 (2009).
   PubMed Web of Science ®Google Scholar
• Gow NA, Netea MG, Munro CA et al. Immune recognition of Candida albicans β-glucan by Dectin-1. J. Infect. Dis.196(10), 1565–1571 (2007).
   PubMed Web of Science ®Google Scholar
• Brown GD, Herre J, Williams DL et al. Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med.197(9), 1119–1124 (2003).
   PubMed Web of Science ®Google Scholar
• Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by Dectin-1 and Toll-like receptor 2. J. Exp. Med.197(9), 1107–1117 (2003).
   PubMed Web of Science ®Google Scholar
• Dennehy KM, Ferwerda G, Faro-Trindade I et al. Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors. Eur. J. Immunol.38(2), 500–506 (2008).
   PubMed Web of Science ®Google Scholar
• Dillon S, Agrawal S, Banerjee K et al. Yeast zymosan, a stimulus for TLR2 and Dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest.116(4), 916–928 (2006).
   PubMed Web of Science ®Google Scholar
• Luther K, Torosantucci A, Brakhage AA, Heesemann J, Ebel F. Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the Dectin-1 β-glucan receptor and Toll-like receptor 2. Cell Microbiol.9(2), 368–381 (2007).
   PubMed Web of Science ®Google Scholar
• Toyotome T, Adachi Y, Watanabe A et al. Activator protein 1 is triggered by Aspergillus fumigatus β-glucans surface-exposed during specific growth stages. Microb. Pathog.44(2), 141–150 (2008).
   PubMedGoogle Scholar
• Jouault T, El Abed-El Behi M, Martinez-Esparza M et al. Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J. Immunol.177(7), 4679–4687 (2006).
   PubMed Web of Science ®Google Scholar
• Agrawal S, Agrawal A, Doughty B et al. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J. Immunol.171(10), 4984–4989 (2003).
   PubMed Web of Science ®Google Scholar
• Gringhuis SI, den Dunnen J, Litjens M et al. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity26(5), 605–616 (2007).
   PubMed Web of Science ®Google Scholar
• Garantziotis S, Hollingsworth JW, Zaas AK, Schwartz DA. The effect of Toll-like receptors and Toll-like receptor genetics in human disease. Annu. Rev. Med.59, 343–359 (2008).
   PubMed Web of Science ®Google Scholar
• Lasker MV, Nair SK. Intracellular TLR signaling: a structural perspective on human disease. J. Immunol.177(1), 11–16 (2006).
   PubMed Web of Science ®Google Scholar
• Rallabhandi P, Bell J, Boukhvalova MS et al. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J. Immunol.177(1), 322–332 (2006).
   PubMed Web of Science ®Google Scholar
• Arbour NC, Lorenz E, Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet.25(2), 187–191 (2000).
   PubMed Web of Science ®Google Scholar
• Michel O, LeVan TD, Stern D et al. Systemic responsiveness to lipopolysaccharide and polymorphisms in the Toll-like receptor 4 gene in human beings. J. Allergy Clin. Immunol.112(5), 923–929 (2003).
   PubMed Web of Science ®Google Scholar
• Van der Graaf CA, Netea MG, Morre SA et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur. Cytokine Netw.17(1), 29–34 (2006).
   PubMed Web of Science ®Google Scholar
• van der Graaf CA, Netea MG, Drenth IP et al.Candida-specific interferon-γ deficiency and Toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis. Neth. J. Med.61(11), 365–369 (2003).
   PubMedGoogle Scholar
• Ryan KR, Hong M, Arkwright PD et al. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED. Clin. Exp. Immunol.154(3), 406–414 (2008).
   PubMed Web of Science ®Google Scholar
• Roilides E, Anastasiou-Katsiardani A, Dimitriadou-Georgiadou A et al. Suppressive effects of interleukin-10 on human mononuclear phagocyte function against Candida albicans and Staphylococcus aureus. J. Infect. Dis.178(6), 1734–1742 (1998).
   PubMedGoogle Scholar
• Del Sero G, Mencacci A, Cenci E et al. Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect.1(14), 1169–1180 (1999).
   PubMed Web of Science ®Google Scholar
• Morre SA, Murillo LS, Spaargaren J, Fennema HS, Pena AS. Role of the Toll-like receptor 4 Asp299Gly polymorphism in susceptibility to Candida albicans infection. J. Infect. Dis.186(9), 1377–1379; author reply 1379 (2002).
   PubMed Web of Science ®Google Scholar
• Netea MG, Sutmuller R, Hermann C et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol.172(6), 3712–3718 (2004).
   PubMed Web of Science ®Google Scholar
• Woehrle T, Du W, Goetz A et al. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine41(3), 322–329 (2008).
   PubMed Web of Science ®Google Scholar
• Carvalho A, Cunha C, Carotti A et al. Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. Exp. Hematol.37(9), 1022–1029 (2009).
   PubMed Web of Science ®Google Scholar
• Carvalho A, Pasqualotto AC, Pitzurra L et al. Polymorphisms in Toll-like receptor genes and susceptibility to pulmonary aspergillosis. J. Infect. Dis.197(4), 618–621 (2008).
   PubMed Web of Science ®Google Scholar
• Kesh S, Mensah NY, Peterlongo P et al. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann. NY Acad. Sci.1062, 95–103 (2005).
   PubMed Web of Science ®Google Scholar
• Bochud PY, Chien JW, Marr KA et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N. Engl. J. Med.359(17), 1766–1777 (2008).
   PubMed Web of Science ®Google Scholar
• Kiechl S, Lorenz E, Reindl M et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med.347(3), 185–192 (2002).
   PubMed Web of Science ®Google Scholar
• Ferwerda B, McCall MB, Alonso S et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl Acad. Sci. USA104(42), 16645–16650 (2007).
   PubMed Web of Science ®Google Scholar
• Glocker EO, Hennigs A, Nabavi M et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med.361(18), 1727–1735 (2009).
   PubMed Web of Science ®Google Scholar
• Cunha C, Di Ianni M, Bozza S et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood DOI 10.1182/blood-2010-04-279307 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• de Vries HS, Plantinga TS, van Krieken JH et al. Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of Dectin-1 in inflammatory bowel disease. PLoS One4(11), e7818 (2009).
   Google Scholar
• Romagne F. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors. Drug Discov. Today12(1–2), 80–87 (2007).
   PubMed Web of Science ®Google Scholar
• McKinley L, Logar AJ, McAllister F et al. Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia. J. Immunol.177(9), 6215–6226 (2006).
   PubMed Web of Science ®Google Scholar
• Montagnoli C, Bacci A, Bozza S et al. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol.169(11), 6298–6308 (2002).
   PubMed Web of Science ®Google Scholar
• Montagnoli C, Fallarino F, Gaziano R et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol.176(3), 1712–1723 (2006).
   PubMed Web of Science ®Google Scholar
• Cavassani KA, Campanelli AP, Moreira AP et al. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J. Immunol.177(9), 5811–5818 (2006).
   PubMed Web of Science ®Google Scholar
• Ezekowitz RA, Sastry K, Bailly P, Warner A. Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J. Exp. Med.172(6), 1785–1794 (1990).
   PubMed Web of Science ®Google Scholar
• McGreal EP, Rosas M, Brown GD et al. The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose. Glycobiology16(5), 422–430 (2006).
   PubMed Web of Science ®Google Scholar
• Cambi A, Gijzen K, de Vries JM et al. The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol.33(2), 532–538 (2003).
   PubMed Web of Science ®Google Scholar
• Edwards L, Williams AE, Krieg AM et al. Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner. Eur. J. Immunol.35(1), 273–281 (2005).
   PubMedGoogle Scholar
• Netea MG, Van der Meer JW, Kullberg BJ. Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol.12(11), 484–488 (2004).
   PubMed Web of Science ®Google Scholar
• Bellocchio S, Gaziano R, Bozza S et al. Liposomal amphotericin B activates antifungal resistance with reduced toxicity by diverting Toll-like receptor signalling from TLR-2 to TLR-4. J. Antimicrob. Chemother.55(2), 214–222 (2005).
   PubMed Web of Science ®Google Scholar
• Sau K, Mambula SS, Latz E et al. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J. Biol. Chem.278(39), 37561–37568 (2003).
   PubMed Web of Science ®Google Scholar